News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
10,041 Results
Type
Article (1051)
Company Profile (1)
Press Release (8989)
Section
Business (3389)
Career Advice (16)
Deals (506)
Drug Delivery (2)
Drug Development (1454)
Employer Resources (8)
FDA (299)
Job Trends (422)
News (5627)
Policy (522)
Tag
Academia (35)
Accelerated approval (3)
Allergies (8)
Alliances (1016)
ALS (3)
Alzheimer's disease (8)
Antibody-drug conjugate (ADC) (6)
Approvals (337)
Artificial intelligence (10)
ASCO (12)
Autoimmune disease (3)
Bankruptcy (4)
Best Places to Work (331)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (2)
Bladder cancer (3)
Breast cancer (7)
Cancer (104)
Cardiovascular disease (23)
Career advice (18)
CAR-T (4)
Cell therapy (12)
Cervical cancer (1)
Clinical research (1316)
Collaboration (43)
Compensation (2)
Complete response letters (2)
COVID-19 (45)
CRISPR (6)
C-suite (36)
Data (114)
Diabetes (9)
Diagnostics (32)
Digital health (2)
Diversity, equity & inclusion (3)
Drug discovery (8)
Drug pricing (2)
Duchenne muscular dystrophy (3)
Earnings (840)
Editorial (2)
Employer branding (5)
Employer resources (8)
Events (1012)
Executive appointments (35)
FDA (383)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (1)
Funding (45)
Gene editing (9)
Generative AI (2)
Gene therapy (26)
GLP-1 (17)
Government (69)
Guidances (5)
Healthcare (145)
Hematology (2)
HIV (1)
IgA nephropathy (1)
Immunology and inflammation (6)
Immuno-oncology (2)
Indications (11)
Infectious disease (46)
Intellectual property (3)
IPO (178)
Job creations (93)
Job search strategy (13)
JPM (1)
Labor market (10)
Layoffs (50)
Leadership (3)
Legal (141)
Liver cancer (8)
Lung cancer (18)
Lymphoma (3)
Management (1)
Manufacturing (13)
Medical device (53)
Medtech (54)
Mergers & acquisitions (351)
Metabolic disorders (21)
mRNA (8)
Neurodegenerative disease (2)
Neuroscience (21)
NextGen: Class of 2026 (70)
Non-profit (35)
Obesity (10)
Opinion (7)
Ovarian cancer (1)
Parkinson's disease (7)
Patents (1)
Patient recruitment (8)
Peanut (3)
People (1423)
Pharmaceutical (1)
Phase 1 (353)
Phase 2 (422)
Phase 3 (654)
Pipeline (126)
Policy (6)
Postmarket research (95)
Preclinical (88)
Prostate cancer (26)
Radiopharmaceuticals (16)
Rare diseases (18)
Real estate (88)
Recruiting (3)
Regulatory (435)
Reports (3)
Research institute (31)
Resumes & cover letters (3)
RSV (1)
Schizophrenia (1)
Series A (8)
Series B (7)
Sickle cell disease (1)
Special edition (1)
Startups (89)
Stomach cancer (1)
Supply chain (3)
The Weekly (9)
Vaccines (5)
Venture capital (7)
Weight loss (6)
Women's health (13)
Worklife (1)
Date
Last 7 days (7)
Last 30 days (31)
Last 365 days (346)
2026 (161)
2025 (380)
2024 (473)
2023 (461)
2022 (1106)
2021 (981)
2020 (851)
2019 (670)
2018 (391)
2017 (506)
2016 (454)
2015 (521)
2014 (357)
2013 (318)
2012 (345)
2011 (391)
2010 (310)
Location
Africa (13)
Arizona (3)
Asia (588)
Australia (80)
California (158)
Canada (28)
China (15)
Colorado (5)
Connecticut (10)
Delaware (1)
Europe (2440)
Florida (10)
Georgia (1)
Hawaii (1)
Idaho (2)
Illinois (2)
India (1)
Indiana (6)
Japan (9)
Kansas (3)
Louisiana (2)
Maine (1)
Maryland (14)
Massachusetts (101)
Michigan (2)
Minnesota (6)
Missouri (4)
New Jersey (84)
New York (149)
North Carolina (21)
Northern California (87)
Ohio (3)
Pennsylvania (11)
Puerto Rico (1)
Rhode Island (1)
South America (17)
Southern California (59)
Tennessee (2)
Texas (5)
United States (566)
Utah (8)
Washington State (3)
10,041 Results for "bayer".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Bayer ends multi-year M&A drought with up to $2.45B Perfuse buy
For $300 million upfront, Bayer is purchasing Perfuse Therapeutics to advance an eye implant for glaucoma and diabetic retinopathy, marking the company’s first pharma acquisition since 2021.
May 6, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Dr. Jost Reinhard Appointed President of Bayer’s Radiology Business
June 9, 2026
·
3 min read
Press Releases
Bayer Completes Acquisition of Perfuse Therapeutics
June 17, 2026
·
3 min read
Press Releases
Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions
June 15, 2026
·
10 min read
Press Releases
Bayer Announces Global Consumer Health Leadership Changes to Accelerate Growth
June 8, 2026
·
3 min read
Press Releases
Phase III FIND‑CKD Results Show Bayer’s KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disease
June 5, 2026
·
16 min read
Press Releases
Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline
May 6, 2026
·
6 min read
Press Releases
Bayer’s KERENDIA® (finerenone) Granted Priority Review of Supplemental New Drug Application by U.S. FDA for Treatment of Adults with Type 1 Diabetes and Chronic Kidney Disease
May 21, 2026
·
13 min read
Lung cancer
Bayer Wins Lung Cancer Accelerated Approval for Kinase Inhibitor
The nod brings Bayer face-to-face in the market with Boehringer Ingelheim and AstraZeneca, each of which has its own HER2 blocker for non-small cell lung cancer.
November 20, 2025
·
1 min read
·
Tristan Manalac
Press Releases
ASCO 2026: Bayer to Present New Data Across Oncology Portfolio
May 21, 2026
·
19 min read
1 of 1,005
Next
